Top news of the week: 02.06.2020.
#CoronaPandemic #news #pharmiweb #biotechnology #CoronaOutbreak #COVID19 #pharma #biospace #lifesciences #pharmaceuticals
Career And Jobs
Biotech VOICES -- The new normal in biotech, by Cygnal CEO Pearl Huang. Big issue --
Coronavirus will change biotech research with remote collaborations
https://t.co/7rxeYyHfER
OpenBiotech Voices: Coronavirus will change biotech research with remote collaborations
When a field that depends on scientific benchwork suddenly moves online, what happens to collaborations and the innovation supply chain? We are seeing the answer to this question play out ...
Book traversal links for The top 15 highest-paid biopharma CEOs of 2019
While the list of the best-paid biopharma CEOs of 2019 includes some of the world's largest drugmakers, you'll also find smaller companies among them. And the CEO at No. 1 could be a ...
Jacobio will work on early global clinical trials of the two leading candidates out of its SHP2 portfolio, namely JAB-3068 and JAB-3312, but now AbbVie will start covering R&D expenses. https://t.co/qzjRB8LhEm
OpenAbbVie pens cancer pact with U.S.-China biotech Jacobio
AbbVie has signed a new pact to focus on SHP2 inhibitors, which target a key node in cancer and immune cells, from early-stage biotech Jacobio Pharmaceuticals.
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG achieves solid growth in the first half of the 2019/20 financial year
https://t.co/tYS7UkyL7k
#news #pharma #pharmiweb
OpenB.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG achieves solid growth in the first half of the 2019/20 financial year
DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Half Year Results29.05.2020 / 08:30 The issuer is solely responsible for the content of this ...
I thought this was interesting: $350M-plus biotech IPO, CEO of mother ship looking to come away with a fortune, for a drug that stole the ASCO show 3 years ago.
$JNJ partnered
https://t.co/ND0aDMHHmp
OpenThe big money: Poised to make drug R&D history, a China biotech unveils unicorn racing ambitions in a bid to raise $350M-plus on Nasdaq
Almost exactly three years after Shanghai-based Legend came out of nowhere to steal the show at ASCO with jaw-dropping data on their BCMA-targeted CAR-T for multiple myeloma, the little ...
Biopharma Update on the Novel Coronavirus: May 28
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/ZHAfejNRTD
OpenBiopharma Update on the Novel Coronavirus: May 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 28, 2020.
“You never know whether you’ll like something until you try it out.”
This week's #SciMagWorkingLife. https://t.co/j4DRd0E3st
OpenWhy I paused my Ph.D. research to work as an industry intern
“You never know whether you’ll like something until you try it out,” the author writes
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action https://t.co/eXzQSkG4Sw https://t.co/J05VekOjwC
OpenBiotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Legend Biotech is living up to its name as it sets terms for a massive $350 million IPO, while early-stage cancer biotech Repare Therapeutics and blood-disease-focused Forma Therapeutics ...